article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

Considerations for a Decentralized Manufacturing Paradigm Trudy Patterson Mon, 09/11/2023 - 06:47 Features September / October 2023 Considerations for a Decentralized Manufacturing Paradigm Marquerita Algorri, PhD Ting Wang, PhD Jocelyn X. 7 June 2023. New Project: Evolutive Vaccines Facility for Sanofi.” McQueen Nina S.

article thumbnail

Laboratory services poised for the digital revolution

Pharmaceutical Technology

Out of all clinical trials estimated to be completed in 2023, at least 5% have a decentralised component. As head of performance, process and risk management for research and development at GSK Vaccines, Jamaels was in charge of R&D covering clinical, medical, regulatory and technical areas.